US$ 20.65
soul trial oral semaglutide cardiovascular outcomes nejm 2025 results Forecasting Trial Milestones: A Predictive Analysis for Early Termination of the SOUL Study Oral Semaglutide's Impact on Cardiovascular
Description
Ozempic not working as expected

Half of adults who start semaglutide for weight loss discontinue within a year, according to a study presented at the annual meeting of the European Association

Kristina C

The presence of concomitant hypertension in diabetics is a major driver of excess cardiovascular risk

Find out how this medication works, side effects to consider, and how long it takes to work.

Taking Ozempic or Mounjaro
